| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Molecular Pathobiology and 2 Third Department of Internal Medicine, Mie University School of Medicine, Tsu-city, Mie 514-8507, Japan
Several growth factors, including platelet-derived growth factor (PDGF), have been implicated in the mechanism of lung and airway remodeling. In the present study, we evaluated whether thrombin may promote lung and airway remodeling by increasing PDGF production from lung and airway epithelial cells. Conditioned medium (CM) was prepared by treating epithelial cells with increasing concentrations of thrombin; before use in the assays, CM was treated with hirudin until complete inhibition of thrombin activity. CM from epithelial cells stimulated the proliferation of lung fibroblasts and bronchial smooth muscle cells. Anti-PDGF antibody significantly inhibited this CM proliferative activity, implicating PDGF in this effect. Enzyme immunoassay and RT-PCR demonstrated that thrombin induced the secretion and expression of PDGF from bronchial and alveolar epithelial cells. RT-PCR showed that epithelial cells express the thrombin receptors protease-activated receptor (PAR)-1, PAR-3, and PAR-4. The PAR-1 agonist peptide was also found to induce PDGF secretion from epithelial cells, suggesting that the cellular effect of thrombin occurs via a PAR-1-mediated mechanism. Overall, this study showed for the first time that thrombin may play an important role in the process of lung and airway remodeling by stimulating the expression of PDGF via its cellular receptor, PAR-1.
coagulation; lung fibrosis; bronchial asthma; platelet-derived growth factor receptor
This article has been cited by other articles:
|
|
 |
|
  G. J. Villares, M. Zigler, H. Wang, V. O. Melnikova, H. Wu, R. Friedman, M. C. Leslie, P. E. Vivas-Mejia, G. Lopez-Berestein, A. K. Sood, et al. Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA Cancer Res., November 1, 2008; 68(21): 9078 - 9086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Siegbahn, M. Johnell, A. Nordin, M. Aberg, and T. Velling TF/FVIIa Transactivate PDGFR to Regulate PDGF-BB Induced Chemotaxis in Different Cell Types: Involvement of Src And PLC Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yuda, Y. Adachi, O. Taguchi, E. C. Gabazza, O. Hataji, H. Fujimoto, S. Tamaki, K. Nishikubo, K. Fukudome, C. N. D'Alessandro-Gabazza, et al. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice Blood, March 15, 2004; 103(6): 2196 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shimizu, E. C. Gabazza, O. Taguchi, H. Yasui, Y. Taguchi, T. Hayashi, M. Ido, T. Shimizu, T. Nakagaki, H. Kobayashi, et al. Activated Protein C Inhibits the Expression of Platelet-derived Growth Factor in the Lung Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1416 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lang, P. I. Song, F. J. Legat, R. M. Lavker, B. Harten, H. Kalden, E. F. Grady, N. W. Bunnett, C. A. Armstrong, and J. C. Ansel Human Corneal Epithelial Cells Express Functional PAR-1 and PAR-2 Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Asokananthan, P. T. Graham, J. Fink, D. A. Knight, A. J. Bakker, A. S. McWilliam, P. J. Thompson, and G. A. Stewart Activation of Protease-Activated Receptor (PAR)-1, PAR-2, and PAR-4 Stimulates IL-6, IL-8, and Prostaglandin E2 Release from Human Respiratory Epithelial Cells J. Immunol., April 1, 2002; 168(7): 3577 - 3585. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
